Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,399,673
-
Total 13F shares
-
47,332,279
-
Share change
-
-176,935
-
Total reported value
-
$902,596,313
-
Price per share
-
$19.58
-
Number of holders
-
100
-
Value change
-
-$4,691,524
-
Number of buys
-
46
-
Number of sells
-
54
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q2 2021
As of 30 Jun 2021 RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) had 100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 47,332,279 shares of stock of the company.
Largest 10 holders included PRIMECAP MANAGEMENT CO/CA/, NEA Management Company, LLC, RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, BAKER BROS. ADVISORS LP, BlackRock Inc., FEDERATED HERMES, INC., VANGUARD GROUP INC, STATE STREET CORP, and DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C).
This table shows 100 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.